CFTR and cystic fibrosis: It presents new opportunities to advance CF gene therapy from conventional gene addition to precise gene correction of any CFTR mutation at the endogenous locus, by which, theoretically, the complexities of CFTR regulation at the cellular level in the lung could be solved (Yan et al., 2019; Vu and McCray, 2020).